CPRX
NASDAQ · Biotechnology
Catalyst Pharmaceuticals Inc
$31.49
+0.01 (+0.03%)
CPRX News25 articles
Angelini Completes $4.1B Catalyst Buyout, Delists From Nasdaq
Angelini Pharma has finalized its $4.1 billion all-cash acquisition of Catalyst Pharmaceuticals, delisting the stock from Nasdaq. The deal reflects an enterprise value of about 5.1 times projected 2026 revenue.
Catalyst Pharmaceuticals Delisted After Angelini Merger Closes
Catalyst Pharmaceuticals was delisted from Nasdaq after Angelini Pharma completed its $4.1 billion acquisition. The stock closed at $31.49, just one cent below the $31.50 cash payout.
Angelini Completes $4.1B Acquisition of Catalyst Pharmaceuticals
Angelini finalized its $4.1 billion acquisition of Catalyst Pharmaceuticals, paying $31.50 per share in cash, valuing the company at 9x 2026 EBITDA.
Critical Metals Surges 20% After Hours Without New Catalyst
CRML surged 20.5% after hours to $8.11 with no fresh filing, while short interest remains elevated at 46.76% of float, raising volatility concerns.
Kanzhun Shares Slide 6% on Heavy Volume, Yet No Catalyst Emerges
Kanzhun's stock dropped 6% on volume 7.8 times average, but no company announcement explains the move. Recent earnings were strong, and a dividend is pending.
Apple's Beats Gaming Controller: A Strategic Services Play, Not Yet a Stock Catalyst
Apple is reportedly developing a Beats-branded gaming controller for iPhone, a move that could boost its services ecosystem. Analysts see limited near-term impact on AAPL stock.
IBM's Swiss Quantum Hub: A Strategic Pipeline Play, Not Yet an Earnings Catalyst
IBM's first Swiss quantum system is a strategic research hub, but without disclosed financial terms, it signals pipeline growth, not immediate revenue. Shares rose 3.96% on Friday.
Netflix's New Dutch Thriller: A Test of Global Engagement, Not a Stock Catalyst
Netflix's latest Dutch thriller tests global engagement, but NFLX valuation depends on durable growth. Watch Top 10 signals.
FTFT Shares Surge 59.5% on Heavy Volume, But No Catalyst Announced
FTFT shares soared 59.5% to $2.09 on heavy volume, but no company news explains the move. The rally appears speculative, with the stock still well below its split-adjusted placement price.
Bitcoin Slips After Jobs Data; CPI Looms as Next Catalyst
Bitcoin's attempt to hold above $80,000 failed after a stronger-than-expected jobs report. Traders now look to next week's CPI data for direction.
Oracle Gains 2.8% as Citi Flags Upcoming Catalysts, Market Cap Jumps $12B
Oracle shares climbed 2.8% after Citi started a 90-day catalyst watch, boosting market value by $12B. Analysts remain bullish despite negative free cash flow.
FreeCast Shares Skyrocket 144% on Record Volume, Yet No Fresh Catalysts Emerge
FreeCast (CAST) jumped 144% to $2.10 on 127.7 million shares, 11x its average volume. No new disclosures accompanied the surge, leaving traders to speculate on the catalyst.
H&M Stock Climbs 3.3% as Citi Flags Positive Catalyst, Yet Analyst Consensus Remains Bearish
H&M shares jumped 3.3% after Citi placed the retailer on positive catalyst watch, but the broader analyst community remains skeptical, with a consensus target implying 13.3% downside.
Chipotle's Mexico Entry: A Growth Test, Not an Earnings Catalyst
Chipotle (CMG) opens its first restaurant in Mexico, but the move is a long-term growth test rather than a near-term earnings driver. International partner stores remain a tiny fraction of operations.
XRP Holds Above $1 as Market Awaits Next Catalyst
XRP holds above $1 support amid cautious crypto market, with technicals and macro data in focus. Ripple's EU license adds regulatory clarity.
CEG Stock Dips as AI Power Catalyst Looms
Constellation Energy closed at $287.75, down 2.1% for the week. A regulatory ruling on restarting Three Mile Island for a Microsoft data center contract could come by July.
Glencore Eyes Monday Catalyst as South Africa Greenlights Ferrochrome Power Relief
Glencore shares ended the week nearly unchanged at 567.80 pence, as South Africa approved a temporary discounted power rate for the Glencore-Merafe ferrochrome venture, offering cost relief ahead of Monday's market open.
NIO Shares End Flat as Market Awaits Post-Earnings Catalysts
NIO shares ended Friday down 7.14% at $5.20, even as U.S. markets rallied. The stock faces headwinds from fierce competition and macro uncertainty, with key catalysts including the ES9 launch and upcoming inflation data.
J&J Stock Dips on Friday but Posts Weekly Gain; Key Catalysts Ahead
J&J shares fell 1.77% Friday amid a broad selloff but still gained 2.4% for the week. Next week, investors watch pipeline data and a medtech launch.
Hims & Hers Soars on FDA Catalyst as Omnicell Underperforms
Hims & Hers Health shares surged nearly 9% Monday, extending a strong weekly gain ahead of its May earnings report and a key FDA meeting on peptides. Omnicell reported mixed Q4 results with a net loss.
HKEX Eyes IPO Revival and Policy Signals as Key Catalysts
HKEX shares gained 0.87% to HK$419.00, with a revived IPO pipeline and upcoming policy meetings in Beijing setting the near-term agenda. The exchange reported record 2025 profits of HK$17.8 billion.
Fortescue Faces Dual Catalysts with Mine Review and Earnings
Fortescue Metals Group shares gained 0.5% as regulators began a public comment period for its proposed Wyloo North iron ore mine, with investors also positioning for the company's half-year financial results scheduled for February 25.
Instacart Parent Soars on Strong Guidance, Eyes Key Catalysts Ahead
Maplebear Inc, parent of Instacart, closed up 9.2% at $36.30 following an upbeat quarterly forecast. The company reported a 14% rise in Q4 gross transaction value to $9.85 billion.
Intel Recovers Slightly After Sharp Sell-Off, Focus Shifts to Upcoming Catalysts
Intel shares edged higher in premarket trading Wednesday, attempting to stabilize after a 6% decline. Investors are assessing macro risks and awaiting the company's upcoming presentation at Mobile World Congress.
Reliance Industries Faces Dual Catalysts: Russian Crude Shift and Australian Acquisition
Reliance Industries shares are poised for attention as reports indicate Indian refiners are avoiding new Russian crude contracts, while its consumer arm secures a majority stake in Australia's Goodness Group.